News About: Pharm. Industry
Time release formulations, keyword for drugmakers
Influenced by the government’s policy to reduce drug prices, more and more pharmaceutical firms are looking to develop time release drug formulations as these formulations are rather advantageous in health insurance p...
KFDA to be flexile over small package system
The Korea Food and Drug Administration is expected to overhaul the controversial small package system to make it “better” for both manufacturers and pharmacists, according to pharmaceutical sources.
The drug agency...
Institut Pasteur Korea to screen Pfizer compound library
Institut Pasteur Korea said on December 7 that it has entered into a Collaborative Agreement with the Drugs for Neglected Diseases Initiative (DNDi), centered on the use of Pfizer’s compound library, for the identific...
FTC approves promotional meetings overseas
The Fair Trade Commission’s recent recognition on promotional meetings to be held at the headquarters of foreign pharmaceutical companies has invited criticism from the local industry.
Critics say it's not fair for...
Lilly Korea starts direct dealing with Dongwon
Lilly Korea has been also involved in direct transactions with an affiliated company of Dongwon Pharma Group in Daegu, sources said recently.
Multination firms, which have been reported to open a direct dealing wit...
Salespersons feel uneasy over predicted sales loss next year
With the year-end approaching, a number of salespersons are skeptical about the prospect of sales loss due to the government’s ruthless price-cut polices.
“We will meet a new year with a lot of negative factors aff...
Battle to get fiercer over local anti-ulcer market
Korean drug makers are expected to wage fiercer campaigns to raise domestic anti-ulcer market share amid forecasts that Ilyang Pharm will emerge as a strong competitor with its Noltec (ilaprazole) new proton pump inhi...
Weekly new product licenses issued
The Korea Food and Drug Administration announced that licenses for new products totaled 53 in the period of November 23-27.
Of the licenses, prescription drugs accounted for 19, OTCs for 10, raw materials for 6 and...
90% of asbestos contaminated medicines are discarded, KFDA says
The Korea Food and Drug Administration says the majority of 122 drugs and medical goods confirmed to have used talc contaminated with asbestos were destroyed, while remaining items will be handled by a divided method....
Daewoong to build 250 billion won plant
Daewoong Pharm says it will invest 250 billion won to build a current Good Manufacturing Practice plant in Chungju by 2013.
To make inroad into overseas markets, we will build a new plant,’’ a company official said...
